Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma

R. C. Fields, V. E. Strong, M. Gönen, K. A. Goodman, N. P. Rizk, D. P. Kelsen, D. H. Ilson, L. H. Tang, M. F. Brennan, D. G. Coit, M. A. Shah

Research output: Contribution to journalArticle

68 Scopus citations

Abstract

Background:To characterise recurrence patterns and survival following pathologic complete response (pCR) in patients who received preoperative therapy for localised gastric or gastrooesophageal junction (GEJ) adenocarcinoma. Methods:A retrospective review of a prospective database identified patients with pCR after preoperative chemotherapy for gastric or preoperative chemoradiation for GEJ (Siewert II/III) adenocarcinoma. Recurrence patterns, overall survival, recurrence-free survival, and disease-specific survival were analysed.Results:From 1985 to 2009, 714 patients received preoperative therapy for localised gastric/GEJ adenocarcinoma, and 609 (85%) underwent a subsequent R0 resection. There were 60 patients (8.4%) with a pCR. Median follow-up was 46 months. Recurrence at 5 years was significantly lower for pCR vs non-pCR patients (27% and 51%, respectively, P0.01). The probability of recurrence for patients with pCR was similar to non-pCR patients with pathologic stage I or II disease. Although the overall pattern of local/regional (LR) vs distant recurrence was comparable (43% LR vs 57% distant) between pCR and non-pCR groups, there was a significantly higher incidence of central nervous system (CNS) first recurrences in pCR patients (36 vs 4%, P0.01).Conclusion:Patients with gastric or GEJ adenocarcinoma who achieve a pCR following preoperative therapy still have a significant risk of recurrence and cancer-specific death following resection. One third of the recurrences in the pCR group were symptomatic CNS recurrences. Increased awareness of the risk of CNS metastases and selective brain imaging in patients who achieve a pCR following preoperative therapy for gastric/GEJ adenocarcinoma is warranted.

Original languageEnglish
Pages (from-to)1840-1847
Number of pages8
JournalBritish Journal of Cancer
Volume104
Issue number12
DOIs
StatePublished - Jun 7 2011
Externally publishedYes

Keywords

  • chemotherapy
  • gastric cancer
  • pathologic complete response
  • radiation therapy
  • surgery

Fingerprint Dive into the research topics of 'Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma'. Together they form a unique fingerprint.

  • Cite this

    Fields, R. C., Strong, V. E., Gönen, M., Goodman, K. A., Rizk, N. P., Kelsen, D. P., Ilson, D. H., Tang, L. H., Brennan, M. F., Coit, D. G., & Shah, M. A. (2011). Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British Journal of Cancer, 104(12), 1840-1847. https://doi.org/10.1038/bjc.2011.175